FR2686605B1 - Nouveaux polypeptides, leur preparation et leur utilisation. - Google Patents

Nouveaux polypeptides, leur preparation et leur utilisation.

Info

Publication number
FR2686605B1
FR2686605B1 FR9200806A FR9200806A FR2686605B1 FR 2686605 B1 FR2686605 B1 FR 2686605B1 FR 9200806 A FR9200806 A FR 9200806A FR 9200806 A FR9200806 A FR 9200806A FR 2686605 B1 FR2686605 B1 FR 2686605B1
Authority
FR
France
Prior art keywords
preparation
novel polypeptides
polypeptides
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9200806A
Other languages
English (en)
Other versions
FR2686605A1 (fr
Inventor
Patrice Denefle
Francoise Guinet
Martine Latta
Anne Murry-Brelier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9200806A priority Critical patent/FR2686605B1/fr
Priority to EP93904117A priority patent/EP0624194A1/fr
Priority to CA002125877A priority patent/CA2125877A1/fr
Priority to PCT/FR1993/000073 priority patent/WO1993015198A1/fr
Priority to JP5512981A priority patent/JPH07503367A/ja
Publication of FR2686605A1 publication Critical patent/FR2686605A1/fr
Application granted granted Critical
Publication of FR2686605B1 publication Critical patent/FR2686605B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9200806A 1992-01-27 1992-01-27 Nouveaux polypeptides, leur preparation et leur utilisation. Expired - Fee Related FR2686605B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9200806A FR2686605B1 (fr) 1992-01-27 1992-01-27 Nouveaux polypeptides, leur preparation et leur utilisation.
EP93904117A EP0624194A1 (fr) 1992-01-27 1993-01-26 Polypeptides derives de l'apolipoproteine aiv humaine, leur preparation et leur utilisation
CA002125877A CA2125877A1 (fr) 1992-01-27 1993-01-26 Polypeptides derives de l'apolipoproteine aiv humaine, leur preparation et leur utilisation
PCT/FR1993/000073 WO1993015198A1 (fr) 1992-01-27 1993-01-26 Polypeptides derives de l'apolipoproteine aiv humaine, leur preparation et leur utilisation
JP5512981A JPH07503367A (ja) 1992-01-27 1993-01-26 ヒト　アポリポタンパク質ａｉｖから透導されたポリペプチド，その製造及びその利用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200806A FR2686605B1 (fr) 1992-01-27 1992-01-27 Nouveaux polypeptides, leur preparation et leur utilisation.

Publications (2)

Publication Number Publication Date
FR2686605A1 FR2686605A1 (fr) 1993-07-30
FR2686605B1 true FR2686605B1 (fr) 1994-03-11

Family

ID=9425980

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9200806A Expired - Fee Related FR2686605B1 (fr) 1992-01-27 1992-01-27 Nouveaux polypeptides, leur preparation et leur utilisation.

Country Status (5)

Country Link
EP (1) EP0624194A1 (fr)
JP (1) JPH07503367A (fr)
CA (1) CA2125877A1 (fr)
FR (1) FR2686605B1 (fr)
WO (1) WO1993015198A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1068239A2 (fr) * 1998-03-31 2001-01-17 University Of Cincinnati Peptides antioxydants
CA2368098A1 (fr) * 1999-06-25 2001-01-04 Genset S.A. Proteines codant des adn complementaires avec des peptides-signal
US7314762B2 (en) * 2001-11-21 2008-01-01 Nanogen, Inc. Apolipoprotein biopolymer markers indicative of insulin resistance
US7125678B2 (en) 2001-11-23 2006-10-24 Nanogen, Inc. Protein biopolymer markers predictive of type II diabetes
US20030100014A1 (en) * 2001-11-23 2003-05-29 George Jackowski Apolipoprotein biopolymer markers predictive of type II diabetes
US20030113808A1 (en) * 2001-12-13 2003-06-19 George Jackowski Apolipoprotein biopolymer markers predictive of alzheimers disease
FR2893136A1 (fr) * 2005-11-10 2007-05-11 Sanofi Aventis Sa Procedes de diagnostic de maladies hepatiques et de criblage de molecules pour le traitement de ces maladies
MX342020B (es) 2011-01-19 2016-09-08 Univ Cincinnati Apolipoproteina a-iv como un peptido antidiabetico.
WO2013109342A1 (fr) * 2012-01-19 2013-07-25 University Of Cincinnati Procédé de traitement du diabète à l'aide d'apolipoprotéine a-iv non glycosylée
CA2878695A1 (fr) * 2012-07-25 2014-01-30 University Of Cincinnati Procede de traitement du diabete de type i a l'aide de l'apolipoproteine aiv
CA2878684A1 (fr) 2012-07-25 2014-01-30 University Of Cincinnati Procede pour traiter des troubles d'hyperglycemie au moyen d'apolipoproteine aiv

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229996B (it) * 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.

Also Published As

Publication number Publication date
EP0624194A1 (fr) 1994-11-17
WO1993015198A1 (fr) 1993-08-05
FR2686605A1 (fr) 1993-07-30
CA2125877A1 (fr) 1993-08-05
JPH07503367A (ja) 1995-04-13

Similar Documents

Publication Publication Date Title
FR2681326B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
FR2573083B1 (fr) Copolymeres organosiloxane-oxyalkylene, leur preparation et leur utilisation
NO894228D0 (no) Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater.
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
FR2629825B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments
FR2686605B1 (fr) Nouveaux polypeptides, leur preparation et leur utilisation.
FR2675511B1 (fr) Nouveaux pigments, leur preparation et leur utilisation.
FR2726831B1 (fr) Nouveaux melanges de colorants, leur preparation et leur utilisation
FR2702930B1 (fr) Iodophores perfectionnes, leur production et leur utilisation.
DE58906056D1 (de) Lockenwickler.
FI904357A0 (fi) Foerfarande foer aktivering av protein c.
FI972965A (fi) Uusia peptidejä, niiden valmistus ja käyttö
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
IT8919113A0 (it) Sci bipattino ripiegabile.
DE59006605D1 (de) Rundkamm.
FR2693199B1 (fr) Nouveaux polypeptides biologiquement actifs, préparation et utilisation.
MA21991A1 (fr) Elements de construction nouveaux .
FR2666812B1 (fr) Enzymes immobilisees, leur preparation et leur utilisation.
FR2598707B1 (fr) Nouveaux agents tensio-actifs, leur preparation et leur utilisation
NO872386L (no) Peptider.
DE69004937D1 (de) Digitales konvergenzsystem.
IT8821191A0 (it) Peptidi anoressizzanti e ipotensivi.
ES1004866Y (es) Sombrilla.
ES1011965Y (es) Sombrilla.
IT8921351A0 (it) Sci da fondo.

Legal Events

Date Code Title Description
ST Notification of lapse